Good morning!

I've had a good response to my new "SCVR Extra" videos on YouTube, so will keep doing those most days, around lunchtime, once I've finished the main written report.

The format is a 10-minute commentary on company announcements that I haven't had time to mention in the main report here. Also it gives me an opportunity to be a little bit more cutting than I would normally be about companies that I don't like, or have a short position on!


Cambridge Cognition Holdings (LON:COG)

Share price: 86p
No. shares: 17.0m
Market Cap: £14.6m

(at the time of writing, I hold a long position in this share)

Investor Teach-In - I attended this event last night, organised by Walbrook PR, and just want to mention how excellent it was. It was well attended, and a really good opportunity to learn about the company, and there was plenty of time to ask questions. We even got to try out the product - tablet-based cognitive reasoning tests with a variety of uses, e.g. to detect early stage dementia, or to prove that drug trials do not impair cognitive functioning.

Sadly I failed the cognitive reasoning test by stage 4, although the scientist from COG made my excuses for me, in that the room was noisy, plus I was on my third beer by that point!

What's interesting about this company is that its academic and clinical trials divisions are already (modestly) profitable & cash generative. The cash generated by those activities are being used to finance a potentially much bigger opportunity in healthcare. The timescales are not immediate, 2-4 years was mentioned, but it's an interesting little company with nice barriers to entry - some patents, but mainly the value of 30-years cumulative data & proof.

It's a difficult company to value, but personally I like to have one or two more speculative shares in my portfolio, and this is potentially interesting in my view. What I particularly like is that the company confirmed they will not need to come back to the market for any more cash for working capital.

The presentation given by the company was well-prepared, and interesting.

I note that the largest shareholder, with 20.2% is Euroblue Investments - an investment vehicle of Nigel Wray (known as Britain's Buffett).

I hope more events like this will be arranged, as it's great to meet companies,…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here